Extendicare (TSE:EXE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

Extendicare (TSE:EXEGet Free Report) had its price objective hoisted by analysts at Canaccord Genuity Group from C$37.00 to C$44.00 in a research note issued on Monday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 36.69% from the company’s previous close.

Several other analysts have also recently commented on EXE. National Bank Financial boosted their price target on shares of Extendicare from C$34.00 to C$40.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 27th. Desjardins reduced their target price on Extendicare from C$40.00 to C$39.00 and set a “buy” rating on the stock in a report on Monday. TD boosted their target price on Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Finally, BMO Capital Markets increased their price target on Extendicare from C$30.00 to C$38.00 in a research note on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of C$35.44.

View Our Latest Research Report on EXE

Extendicare Price Performance

EXE traded down C$0.25 during trading on Monday, reaching C$32.19. 363,614 shares of the company traded hands, compared to its average volume of 388,127. The company has a market cap of C$3.05 billion, a P/E ratio of 23.69 and a beta of 1.59. The company has a debt-to-equity ratio of 82.55, a quick ratio of 0.98 and a current ratio of 1.44. Extendicare has a 12-month low of C$12.64 and a 12-month high of C$39.14. The firm has a fifty day simple moving average of C$35.24 and a 200 day simple moving average of C$30.25.

Extendicare (TSE:EXEGet Free Report) last released its earnings results on Thursday, August 6th. The company reported C$0.32 EPS for the quarter. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The firm had revenue of C$611.04 million for the quarter. On average, equities analysts forecast that Extendicare will post 0.6134729 EPS for the current year.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Further Reading

Analyst Recommendations for Extendicare (TSE:EXE)

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.